Front-line health care workers, including Jacobs School of Medicine and Biomedical Sciences faculty and medical residents, have begun receiving their COVID-19 vaccines, with some already receiving their second dose.
Thomas D. Grant, PhD, assistant professor of structural biology, is co-principal investigator on a grant from the National Science Foundation (NSF) to study how small molecules bind to the SARS-COV-2 protease to understand drug binding and help aid drug design.
Memory loss associated with Alzheimer’s disease may be able to be treated by inhibiting certain enzymes involved in abnormal gene transcription, according to a preclinical study led by senior author Zhen Yan, PhD.
At the start of the pandemic, research teams around the world began conducting studies to help further research related to vaccines for the SARS-CoV-2 coronavirus. A team led by Jonathan F. Lovell, PhD, was one of them.
Bruce R. Troen, MD, professor of medicine and chief of the Division of Geriatrics and Palliative Medicine, wants people to know that a study published this month in the Annals of Internal Medicine — which shows no benefit from higher doses of vitamin D in the frail elderly — is not the final chapter on how vitamin D affects this population.
Joseph Terrell Smith Jr., PhD, postdoctoral fellow in microbiology and immunology, has been awarded a three-year, $202,000 F32 grant from the National Institute of Allergy and Infectious Diseases to study the regulation of RNA in Trypanosoma brucei.
A fourth-year medical student in the Jacobs School of Medicine and Biomedical Sciences has been selected to participate in the American Medical Association (AMA) Foundation’s 2020-2021 Leadership Development Institute.
A Phase 2 research study led by Teresa Quattrin, MD, UB Distinguished Professor of pediatrics and senior associate dean for research integration, shows that the drug golimumab preserves beta-cell function in children and young adults with newly-diagnosed Type 1 diabetes for at least a year after diagnosis.
A study of 24-to-28-month-old mice, the equivalent of 65-to-80-year-old adults, has found that frailty can be slowed with what might be considered “over” supplementation with vitamin D, referred to as “hypersufficiency.”
Researchers at the Jacobs School of Medicine and Biomedical Sciences have published a paper that is helping to define the best time to give a specific treatment to infants born with Krabbe disease (KD).
Cytocybernetics, the UB spinoff co-founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, is aiding in the effort to clear candidate drug therapies for COVID-19 in a fast, effective and safe manner.
Western New Yorkers who were recently exposed to a household member who has tested positive for COVID-19 now have an opportunity to be treated with a promising drug being investigated for COVID-19 infection.